View all Products
RXQ Compounding produces Avastin syringes for intravitreal injection for hospital and clinical settings for the treatment of wet macular edema. We currently compound these into tuberculin syringes (without attached needle) in fill volumes of Avastin 25mg/ml – 0.1ml, 0.12ml, and 0.15ml. We work with our customers to establish standing orders and shipments of the needed quantities for clinic patient treatment. End-product testing of Avastin syringes requires approximately 3 weeks and quantities can be modified as clinic schedules vary.
Product & Service Guarantee
RXQ Compounding is committed to the high quality of our products and our service. All products are end tested for sterility, endotoxins, and potency. The results of this testing creates Beyond Use Dating (BUD) for each product and determines the maximum shelf life of the product. All products are tested to the maximum stability testing point achievable to help reduce time restraints on pharmacy ordering and volume need.
Our commitment to quality goes further than just our products. RXQ is dedicated to great customer service and customer satisfaction. RXQ competitively prices our products so that the cost savings associated with bulk compounding are passed onto our customers. All orders are processed as quickly as possible, and can be typically shipped within 1-2 business days.